_MACHINE TRANSLATION_
The Management Board of Bioceltix S.A. with its registered office in Wrocław (the “Issuer” or the “Company”) hereby informs that on 29 July 2026 it became aware that on 24 July 2026 the District Court for Wrocław-Fabryczna in Wrocław, 6th Commercial Division of the National Court Register, registered amendments to the Company’s Articles of Association resulting from Resolution No. 22/06/2026 of the Ordinary General Meeting of the Company dated 16 July 2026.
Pursuant to Resolution No. 22/06/2026 dated 16 July 2026, the Ordinary General Meeting of the Company amended § 7A of the Company’s Articles of Association (regarding the conditional share capital, in connection with the Company’s incentive programme adopted under Resolution No. 21/06/2026 of the Ordinary General Meeting of the Company dated 16 July 2026).
Previous amount of the conditional share capital: PLN 29,267.90 (twenty-nine thousand two hundred sixty-seven zlotys and ninety groszy).
New amount of the conditional share capital: PLN 24,782.50 (twenty-four thousand seven hundred eighty-two zlotys and fifty groszy).
Accordingly, the Management Board of the Issuer hereby publishes, as attachments to this current report, a detailed summary of the amendments to the Company’s Articles of Association (Attachment No. 1) and the consolidated text of the Company’s Articles of Association reflecting the registration of the above amendments (Attachment No. 2).
Detailed legal basis: § 5(1) and § 6(1) of the Regulation of the Minister of Finance of 6 June 2025 on current and periodic information to be disclosed by issuers of securities and on conditions for recognizing as equivalent information required under the laws of a non-member state.
Attachments:
Załącznik_1_Zmiany_Statutu
Załącznik_2_Tekst_Jednolity_Statutu
Signatures of persons representing the Company:
Łukasz Bzdzion – President of the Management Board
Paweł Wielgus – Member of the Management Board